Cargando…

Glycemic control in type 2 diabetes mellitus prevents coronary arterial wall infection

BACKGROUND: Diabetes mellitus (DM) is a very well-known risk factor for development of atherosclerosis, and it has been hypothesized that poor glycemic control and hyperglycemia plays a major role in this process. In the current study, we aimed to evaluate the associates of poor glycemic control in...

Descripción completa

Detalles Bibliográficos
Autores principales: Izadi, Morteza, Fazel, Mojgan, Karbasi-Afshar, Reza, Saadat, Seyed Hassan, Nasseri, Mohammad Hassan, Jonaidi-Jafari, Nematollah, Ranjbar, Reza, Kazemi-Saleh, Davood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144376/
https://www.ncbi.nlm.nih.gov/pubmed/25161684
_version_ 1782332048382361600
author Izadi, Morteza
Fazel, Mojgan
Karbasi-Afshar, Reza
Saadat, Seyed Hassan
Nasseri, Mohammad Hassan
Jonaidi-Jafari, Nematollah
Ranjbar, Reza
Kazemi-Saleh, Davood
author_facet Izadi, Morteza
Fazel, Mojgan
Karbasi-Afshar, Reza
Saadat, Seyed Hassan
Nasseri, Mohammad Hassan
Jonaidi-Jafari, Nematollah
Ranjbar, Reza
Kazemi-Saleh, Davood
author_sort Izadi, Morteza
collection PubMed
description BACKGROUND: Diabetes mellitus (DM) is a very well-known risk factor for development of atherosclerosis, and it has been hypothesized that poor glycemic control and hyperglycemia plays a major role in this process. In the current study, we aimed to evaluate the associates of poor glycemic control in Iranian patients who have already undergone coronary artery bypass grafting (CABG), with especial focus on the inhabitation of infectious agents within the coronary arterial wall. METHODS: In January 2010, 52 consecutive patients with type 2 DM who undergone CABG at the Department of Cardiovascular Surgery of Baqiyatallah University of Medical Sciences (Tehran, Iran) were included into this cross-sectional study and biopsy specimens from their coronary plaques were taken and analyzed by polymerase chain reaction (PCR) methods for detecting Helicobacter species, cytomegalovirus (CMV) and Chlamydia pneumoniae, and their potential relation to the glycemic control status in these patients. RESULTS: Compared to that in diabetic patients with mean fasting blood sugar (FBS) levels FBS < 126, atherosclerotic lesions in type 2 diabetic patients with poor glycemic control (FBS > 126) were significantly more likely to be positive for CMV PCR test (41% vs. 9%, respectively; P = 0.05). In laboratorial test results, mean triglyceride level was significantly higher among patients of poor glycemic control (168 ± 89 vs. 222 ± 125 mg/dl, respectively; P = 0.033). Hypertension was also significantly more prevalent in this population (73% vs. 36%, respectively; P = 0.034). CONCLUSION: Type 2 diabetic patients with poor glycemic control can be at higher risk for developing CMV infection in their coronary arterial wall, which can promote atherosclerosis formation process in this patient population. According to the findings of this study, we recommend better control of serum glucose levels in type 2 diabetic patients to prevent formation/progression of atherosclerosis.
format Online
Article
Text
id pubmed-4144376
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-41443762014-08-26 Glycemic control in type 2 diabetes mellitus prevents coronary arterial wall infection Izadi, Morteza Fazel, Mojgan Karbasi-Afshar, Reza Saadat, Seyed Hassan Nasseri, Mohammad Hassan Jonaidi-Jafari, Nematollah Ranjbar, Reza Kazemi-Saleh, Davood ARYA Atheroscler Original Article BACKGROUND: Diabetes mellitus (DM) is a very well-known risk factor for development of atherosclerosis, and it has been hypothesized that poor glycemic control and hyperglycemia plays a major role in this process. In the current study, we aimed to evaluate the associates of poor glycemic control in Iranian patients who have already undergone coronary artery bypass grafting (CABG), with especial focus on the inhabitation of infectious agents within the coronary arterial wall. METHODS: In January 2010, 52 consecutive patients with type 2 DM who undergone CABG at the Department of Cardiovascular Surgery of Baqiyatallah University of Medical Sciences (Tehran, Iran) were included into this cross-sectional study and biopsy specimens from their coronary plaques were taken and analyzed by polymerase chain reaction (PCR) methods for detecting Helicobacter species, cytomegalovirus (CMV) and Chlamydia pneumoniae, and their potential relation to the glycemic control status in these patients. RESULTS: Compared to that in diabetic patients with mean fasting blood sugar (FBS) levels FBS < 126, atherosclerotic lesions in type 2 diabetic patients with poor glycemic control (FBS > 126) were significantly more likely to be positive for CMV PCR test (41% vs. 9%, respectively; P = 0.05). In laboratorial test results, mean triglyceride level was significantly higher among patients of poor glycemic control (168 ± 89 vs. 222 ± 125 mg/dl, respectively; P = 0.033). Hypertension was also significantly more prevalent in this population (73% vs. 36%, respectively; P = 0.034). CONCLUSION: Type 2 diabetic patients with poor glycemic control can be at higher risk for developing CMV infection in their coronary arterial wall, which can promote atherosclerosis formation process in this patient population. According to the findings of this study, we recommend better control of serum glucose levels in type 2 diabetic patients to prevent formation/progression of atherosclerosis. Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2014-05 /pmc/articles/PMC4144376/ /pubmed/25161684 Text en © 2014 Isfahan Cardiovascular Research Center & Isfahan University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Izadi, Morteza
Fazel, Mojgan
Karbasi-Afshar, Reza
Saadat, Seyed Hassan
Nasseri, Mohammad Hassan
Jonaidi-Jafari, Nematollah
Ranjbar, Reza
Kazemi-Saleh, Davood
Glycemic control in type 2 diabetes mellitus prevents coronary arterial wall infection
title Glycemic control in type 2 diabetes mellitus prevents coronary arterial wall infection
title_full Glycemic control in type 2 diabetes mellitus prevents coronary arterial wall infection
title_fullStr Glycemic control in type 2 diabetes mellitus prevents coronary arterial wall infection
title_full_unstemmed Glycemic control in type 2 diabetes mellitus prevents coronary arterial wall infection
title_short Glycemic control in type 2 diabetes mellitus prevents coronary arterial wall infection
title_sort glycemic control in type 2 diabetes mellitus prevents coronary arterial wall infection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144376/
https://www.ncbi.nlm.nih.gov/pubmed/25161684
work_keys_str_mv AT izadimorteza glycemiccontrolintype2diabetesmellituspreventscoronaryarterialwallinfection
AT fazelmojgan glycemiccontrolintype2diabetesmellituspreventscoronaryarterialwallinfection
AT karbasiafsharreza glycemiccontrolintype2diabetesmellituspreventscoronaryarterialwallinfection
AT saadatseyedhassan glycemiccontrolintype2diabetesmellituspreventscoronaryarterialwallinfection
AT nasserimohammadhassan glycemiccontrolintype2diabetesmellituspreventscoronaryarterialwallinfection
AT jonaidijafarinematollah glycemiccontrolintype2diabetesmellituspreventscoronaryarterialwallinfection
AT ranjbarreza glycemiccontrolintype2diabetesmellituspreventscoronaryarterialwallinfection
AT kazemisalehdavood glycemiccontrolintype2diabetesmellituspreventscoronaryarterialwallinfection